Proofpoint to Report Third Quarter 2016 Financial Results
Oct 03, 2016 20:05 pm UTC| Business
SUNNYVALE, Calif., Oct. 03, 2016 -- Proofpoint, Inc. (NASDAQ:PFPT), a leading next-generation security and compliance company, today announced it will issue a press release reporting financial results for the third...
Green Plains Acquires Fleischmann’s Vinegar Company
Oct 03, 2016 20:02 pm UTC| Business
$250 million acquisition of the world’s largest manufacturer and marketer of food-grade industrial vinegarAdjacent business addition with significant growth opportunitiesAcquisition is immediately accretive to earnings and...
Oct 03, 2016 20:02 pm UTC| Business
OXFORD, United Kingdom and MARLBOROUGH, Mass., Oct. 03, 2016 -- Oxford Immunotec Global PLC(Nasdaq:OXFD), a global, high-growth diagnostics company focused on developing and commercializing proprietary tests for the...
SBA Communications Corporation Board Approves REIT Conversion
Oct 03, 2016 20:01 pm UTC| Business
BOCA RATON, Fla., Oct. 03, 2016 -- SBA Communications Corporation (NASDAQ:SBAC) (“SBA”) announced today that its Board of Directors has authorized SBA to take all necessary steps for it to qualify as a real estate...
Editas Medicine to Present at the Jefferies Gene Editing/Therapy Summit
Oct 03, 2016 20:01 pm UTC| Business
CAMBRIDGE, Mass., Oct. 03, 2016 -- Editas Medicine, Inc. (NASDAQ:EDIT), a leading genome editing company, announced today that it will present at 9:00 a.m. ET and participate in a panel discussion at 10:00 a.m. ET at...
Bank SNB Opens New Facility at Domain Northside
Oct 03, 2016 19:30 pm UTC| Business
AUSTIN, Texas, Oct. 03, 2016 -- Bank SNB has officially opened its new state-of-the-art facility in the heart of the Domain Northside entertainment district. ...
Paratek Pharmaceuticals, Inc. (Nasdaq: PRTK) to Ring The Nasdaq Stock Market Closing Bell
Oct 03, 2016 19:19 pm UTC| Business
ADVISORY, Oct. 03, 2016 -- What:Paratek Pharmaceuticals, Inc.(Nasdaq:PRTK), a biopharmaceutical company focused on the development and commercialization of innovative therapies based upon its expertise in novel...